| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/15/2010 | WO2009129460A4 Clonidine formulations in a biodegradable polymer carrier |
| 04/15/2010 | WO2009123934A3 Branched multifunctional nanoparticle conjugates and their use |
| 04/15/2010 | US20100094418 Method for preparing a composite material, resulting material and use thereof |
| 04/15/2010 | US20100094408 Drug-Delivery Endovascular Stent and Method for Treating Restenosis |
| 04/15/2010 | US20100094041 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues |
| 04/15/2010 | US20100093875 Granular preparation prevented from caking |
| 04/15/2010 | US20100093874 Copolymer including betaine units and hydrophobic and/or amphiphilic units, method for preparing same and uses thereof |
| 04/15/2010 | US20100093872 Stable aqueous formulations of water insoluble or poorly soluble drugs |
| 04/15/2010 | US20100093866 Pharmaceutical Formulations |
| 04/15/2010 | US20100093783 Composition for treatment of common cold |
| 04/15/2010 | US20100093736 Aminoalcohol and biocide compositions for aqueous based systems |
| 04/15/2010 | US20100093686 Coatings with crystallized active agent(s) and methods |
| 04/15/2010 | US20100093673 Pain relieving patch |
| 04/15/2010 | US20100093544 Adjuvant composition |
| 04/15/2010 | US20100092568 Drug microparticles |
| 04/15/2010 | US20100092566 Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 04/15/2010 | US20100092564 Composition of and Method for Preparing Orally Disintegrating Tablets |
| 04/15/2010 | US20100092548 Chewable softgel capsules |
| 04/15/2010 | US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom |
| 04/15/2010 | US20100092540 Drug delivery compositions and medical devices containing block copolymer |
| 04/15/2010 | US20100092525 Medical device |
| 04/15/2010 | US20100092449 Treatment of Pompe's Disease |
| 04/15/2010 | US20100092419 Magnetic fluids and their use |
| 04/15/2010 | US20100092418 enhancing or modifying fragrance formulation by incorporating an olfactory acceptable amount of the endo isomeric bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, ethyl ester |
| 04/15/2010 | US20100092408 Resilient personal care composition comprising polyalkyl ether containing siloxane elastomers |
| 04/15/2010 | DE102008050924A1 Pigmente Pigments |
| 04/15/2010 | CA2748995A1 Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same |
| 04/15/2010 | CA2740124A1 Use of scyllo-inositols for the treatment of macular degeneration-related disorders |
| 04/15/2010 | CA2740046A1 Detection of granulosa-cell tumors |
| 04/15/2010 | CA2739897A1 Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| 04/15/2010 | CA2739757A1 Hpma - docetaxel or gemcitabine conjugates and uses therefore |
| 04/15/2010 | CA2739710A1 Pharmaceutical composition |
| 04/15/2010 | CA2739546A1 Polysaccharides containing carboxyl functional groups substituted by a hydrophobic alcohol derivative |
| 04/15/2010 | CA2739353A1 Corticosteroid compositions and methods of treatments thereof |
| 04/15/2010 | CA2739246A1 Sustained release drug delivery system |
| 04/15/2010 | CA2739078A1 Biodegradable polymer - bioactive moiety conjugates |
| 04/15/2010 | CA2738831A1 Tacrolimus preparation for external applications |
| 04/15/2010 | CA2737400A1 Pharmaceutical formulation 514 |
| 04/14/2010 | EP2174953A1 Compositions and methods for the diagnosis and treatment of tumor |
| 04/14/2010 | EP2174951A2 Mutant of granulocyte-colony stimulating factor (G-CSF) and chemically conjugated polypeptide thereof |
| 04/14/2010 | EP2174941A1 Isosorbide-derivatives |
| 04/14/2010 | EP2174663A1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (TFPI) or tissue factor pathway inhibitor variant |
| 04/14/2010 | EP2174660A1 Composition for mucosal administration containing agent for accelerating mucosal absorption of peptide drug and administration method thereof |
| 04/14/2010 | EP2174655A1 Spherical microcapsules comprising GLP-1 peptides, their production and use |
| 04/14/2010 | EP2174651A1 A polymer-free hydrogel |
| 04/14/2010 | EP2174647A1 Gel-like composition for external application comprising adenine compound |
| 04/14/2010 | EP2174646A1 Inverted vesicle |
| 04/14/2010 | EP2173775A1 Hyaluronic acid derivatives containing groups able to release no |
| 04/14/2010 | EP2173386A2 Use of vhh antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications |
| 04/14/2010 | EP2173385A1 Chlorotoxins as drug carriers |
| 04/14/2010 | EP2173383A1 Hydrolysable polymeric fmoc-linker |
| 04/14/2010 | EP2173382A1 Wound repair composition and method |
| 04/14/2010 | EP2173377A1 Antibody-endostatin fusion protein and its variants |
| 04/14/2010 | EP2173357A2 Metal complexes incorporated within biodegradable nanoparticles and their use |
| 04/14/2010 | EP2173325A1 Peptide slow-release formulations |
| 04/14/2010 | EP2173321A2 Tablettable formulations of lipophilic health ingredients |
| 04/14/2010 | EP2173189A2 Method for producing stable powder compositions |
| 04/14/2010 | EP1586315B1 Skin lightening composition |
| 04/14/2010 | EP1576089B1 Expansion of renewable stem cell populations |
| 04/14/2010 | EP1458414B1 Use of thrombin inhibitors coupled to polyalkylene glycol in tumour therapy |
| 04/14/2010 | EP1171507B1 Core-shell tectodendrimers |
| 04/14/2010 | CN1965802B Injectable hydrogel preparation of pegylated medicament and preparing method thereof |
| 04/14/2010 | CN1943560B Sandwich structure magnetic composite micro ball with functional shell layer and its preparing method |
| 04/14/2010 | CN1891300B Benzocaine film-formed gel composition and its use |
| 04/14/2010 | CN1859920B Probiotic storage and delivery |
| 04/14/2010 | CN1607950B A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
| 04/14/2010 | CN101694497A Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 04/14/2010 | CN101693736A Novel peptides |
| 04/14/2010 | CN101693181A Silicon oxide and protamine microcapsule and preparation method thereof |
| 04/14/2010 | CN101693113A Divalproex sodium medicine composition with improved oral absorptivity |
| 04/14/2010 | CN101693112A Deoxypodophyllotoxin cyclodextrin inclusion compound, preparation method and antitumor application thereof |
| 04/14/2010 | CN101693111A Method for increasing entrapment rate of polylactic acid microspheres to water soluble protein |
| 04/14/2010 | CN101693110A Method for improving dispersivity of grease-contained traditional Chinese medicinal granules in water |
| 04/14/2010 | CN101693069A External preparation for treating soft tissue injuries and preparation method thereof |
| 04/14/2010 | CN101693043A Pharmaceutical plaster substrate, preparation method and applications thereof |
| 04/14/2010 | CN101693041A Transdermal zinc supplement |
| 04/14/2010 | CN101693030A External medicine composition used for relieving pain and preparation method thereof |
| 04/14/2010 | CN101693029A Oral preparation having improved bioavailability |
| 04/14/2010 | CN101693023A Transparent transdermal nicotine delivery device |
| 04/14/2010 | CN101693022A Method for preparing resveratrol sustained-release capsule capable of preventing rheumatoid arthritis |
| 04/14/2010 | CN101693021A Organic/inorganic hybridized microcapsule prepared in biomimetic way by simulated body fluid method and preparation method thereof |
| 04/14/2010 | CN101693020A Enteric soluble medicine empty capsule prepared by replacing part of gelatin with defatted soybean meal extractive and preparation process |
| 04/14/2010 | CN101693019A Doxycycline hydrochloride oral disintegrating tablet for domestic fowls and preparation method thereof |
| 04/14/2010 | CN101693018A Amoxicillin oral disintegrating tablet for domestic fowls and preparation method thereof |
| 04/14/2010 | CN101693017A Medicament composition of levetiracetam and preparation process |
| 04/14/2010 | CN101693016A Universal pharmaceutical formulation for recombined human serum albumin fusion proteins for injection |
| 04/14/2010 | CN101693015A Coenzyme A medicament freeze-drying preparation and process for preparing same |
| 04/14/2010 | CN101693014A Process for preparing coenzyme A medicament freeze drying preparation |
| 04/14/2010 | CN101693013A Ginseng stem leaf saponin granule for beasts and birds and preparation method thereof |
| 04/14/2010 | CN101693012A Preparation and application of florfenicol slowly-releasing micropill for treating animal digestive canal infection |
| 04/14/2010 | CN101693011A Preparation method of magnetic medicine-carrying nano-particle |
| 04/14/2010 | CN101693010A Cefathiamidine prosoma liposome preparation |
| 04/14/2010 | CN101693009A Antiparasitic closantel sodium transdermal solution for ox and sheep and preparation method thereof |
| 04/14/2010 | CN101693008A Ofloxacin injection and preparation process thereof |
| 04/14/2010 | CN101692894A Use of multi-layer pigments in the food and pharmaceutical industry |
| 04/14/2010 | CN101461932B Medicament composition for treating children's damp-heat diarrhea induced by spleen insufficiency and preparation method thereof |
| 04/14/2010 | CN101396339B Novel degradable lacrimal passage plug and preparation method thereof |
| 04/14/2010 | CN101327183B Method for preparing chitosan in situ gel agent |
| 04/14/2010 | CN101280317B FAK and EGFR targeted RNA interference plasmid-lipidosome antineoplastic complex |
| 04/14/2010 | CN101254184B Salviol acid B phosphatide complexes and method of preparing the same |